The spectrum of non alcoholic fatty liver disease in morbidly obese patients. Prevalence and associate risk factors

Acta Cirurgica Brasileira

Volumn 28, Issue 11, 2013, Pages 788-793

  Feijó, Suerda Guiomar ^a   Lima, José Milton de Castro ^b   de Oliveira, Maria Aparecida Alves ^b   Patrocínio, Régia Maria Vidal ^b   Moura Junior, Luis Gonzaga ^c   Campos, Antônio Borges ^b   Lima, José Wellington Oliveira ^b   Braga, Lúcia Libanez Bessa Campelo ^b  

^a Ceara Federal University Medical School   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Bariatric surgery; Fatty liver; Morbid; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BIOPSY NEEDLE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MALLORY BODY; METABOLIC SYNDROME X; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGE FACTORS; BARIATRIC SURGERY; BIOPSY, FINE-NEEDLE; BODY MASS INDEX; BRAZIL; EPIDEMIOLOGIC METHODS; FATTY LIVER; FEMALE; FIBROSIS; HUMANS; LIVER; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84890050071     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502013001100008     Document Type: Article

References (24)

1. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25:883-9.
2. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(3 Suppl 1):S5-10.
3. Blackburn GL, Mun EC. Effects of weight loss surgeries on liver disease. Semin Liver Dis. 2004;24(4):371-9.
4. Wang JT, Liu YL. Non-alcoholic fatty liver disease: the problems we are facing. Hepatobiliary Pancreat Dis Int. 2003;2(3):334-7.
5. Dixon JB, Bhatal PS, Obrien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in severely obese. Gastroenterology. 2001;121:91-100.
6. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients under going bariatric surgery. J Hepatol. 2006;45(4):600-6.
7. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPARγ ligand rosiglitazone. Hepatology. 2003;38:1008-17.
8. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26 Suppl 1:S5-20.
9. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28(11):2745-9.
10. Cronk C, Roche AF. Race and soc-specific reference data for triceps and subcapsular skinfolds and weight/stature. Am J Clin Nutr. 1998;35:347-54.
11. Brunt EM, Janney CJ, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Non-alcoholic steatohepatitis: a proposal for grading and staging the histologic lesions. Am J Gastroenterol. 1999;94:2467-74.
12. Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Portal fibrosis and hepatic steatosis in morbidly obese subjects: spectrum of nonalcoholic fatty liver disease. Hepatology. 2004;40:475-83.
13. Sanyal AJ. Aga: technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705-25.
14. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR Jr. Gamma-glutamyltransferase and diabetes a 4 year follow-up study. Diabetologia. 2003;46:359-64.
15. Yokoyama H, Moriya S, Homma Y, Ogawa T. Association between gamma-glutamyl transpeptidase activity and status of disorders constituting insulin resistance syndrome. Alcohol Clin Exp Res. 2003;27:225-55.
16. Wanless IR, Bargman JM, Oreopoulus DG, Vas SI. Subcapsular steatonecrosis in response to peritoneal insuline delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol. 1989;2:69-74.
17. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532-40.
18. Lima ML, Mourão SC, Diniz MT, Leite VH. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. Obes Surg. 2005;15(5):661-9.
19. Júnior WS, Nonino-Borges CB. Clinical predictors of different grades of nonalcoholic fatty liver disease. Obes Surg. 2012;22(2):248-52.
20. Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V, Kitsanta P, Argyrakos T, Hadjiyannakis E. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg. 2005;15(8):1154-60.
21. Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003;138:1240-44.
22. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 2006;26:856-63.
23. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95.
24. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37(6):1286-92.